Image-Guided Biopsy: Needle Biopsy Under Imaging Guidance

Image-guided biopsy is a minimally invasive procedure in which a radiologist uses real-time imaging — ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), or fluoroscopy — to direct a needle precisely to a target tissue and extract a sample for pathological analysis. The procedure bridges diagnostic and interventional radiology, enabling tissue diagnosis without open surgery. Accurate needle placement under imaging guidance is foundational to oncologic staging, infection workup, and the evaluation of indeterminate lesions across virtually every organ system.

Definition and scope

Image-guided biopsy encompasses any percutaneous tissue-sampling technique in which imaging is used to confirm needle position before, during, or after sample acquisition. The American College of Radiology (ACR) classifies these procedures within interventional radiology practice guidelines, and the Centers for Medicare and Medicaid Services (CMS) reimburses them under distinct Current Procedural Terminology (CPT) codes that distinguish the imaging modality used and the anatomic site targeted.

The scope of image-guided biopsy extends from superficial soft-tissue lesions accessible under ultrasound to deep retroperitoneal masses requiring CT guidance, and to lesions detectable only on MRI — such as non-mass enhancement in the breast identified at mammography screening and further characterized by breast MRI. The regulatory context for radiology in the United States requires that facilities performing these procedures meet accreditation standards set by the ACR or the Joint Commission, and that performing physicians demonstrate competency in both the imaging modality and the biopsy technique.

Three broad categories define the procedural landscape:

  1. Core needle biopsy (CNB) — Uses a spring-loaded or vacuum-assisted device, typically 14- to 18-gauge, to extract cylindrical tissue cores suitable for histologic analysis, immunohistochemistry, and molecular testing.
  2. Fine needle aspiration (FNA) — Uses a 22- to 25-gauge needle to harvest cells for cytologic evaluation; lower tissue volume limits histologic architecture assessment.
  3. Vacuum-assisted biopsy (VAB) — Employs suction in addition to mechanical cutting, enabling acquisition of larger-volume samples through a single needle insertion; widely used in breast biopsy under stereotactic or MRI guidance.

How it works

The procedure follows a structured sequence regardless of the imaging modality employed:

  1. Pre-procedure planning — Cross-sectional imaging (CT or MRI) or prior ultrasound defines the target lesion, its depth, and the optimal approach trajectory that avoids critical structures such as major vessels, bowel, or pleura.
  2. Patient positioning and sterile preparation — The patient is positioned to optimize needle access; the skin is sterilized and draped per standard surgical aseptic technique, consistent with CDC guidelines on infection prevention for minor surgical procedures.
  3. Local anesthesia — Lidocaine is infiltrated along the planned needle track. For deep CT-guided procedures, conscious sedation may be administered under monitored anesthesia care protocols.
  4. Imaging localization — Real-time or intermittent imaging confirms needle tip position relative to the target. Ultrasound permits continuous visualization; CT guidance uses sequential axial images to confirm depth and angle; MRI guidance employs MR-compatible needle systems to avoid ferromagnetic artifact.
  5. Sample acquisition — The biopsy device is fired (CNB) or suction applied (VAB) at the confirmed target position. Multiple passes — typically 3 to 6 cores for CNB — are obtained to ensure diagnostic adequacy, a threshold supported by ACR practice parameters.
  6. Post-biopsy imaging — Immediate post-procedure imaging assesses for complications such as pneumothorax after lung biopsy or hematoma formation. A radiopaque marker clip is often deployed at the biopsy site to enable future localization.
  7. Specimen handling — Cores are placed in formalin or, for lymphoma or molecular profiling, in specialized media per the receiving pathology laboratory's protocol.

The entire process, from imaging setup to specimen submission, typically requires 30 to 90 minutes depending on site complexity and guidance modality.

Common scenarios

Image-guided biopsy is applied across organ systems where non-invasive imaging cannot alone establish a definitive tissue diagnosis:

Decision boundaries

Not every suspicious lesion requires biopsy, and not every biopsy is safely performed percutaneously. The decision to proceed involves clinical, imaging, and patient-specific variables:

Biopsy is generally appropriate when:
- Imaging findings are indeterminate and tissue diagnosis will change clinical management
- A lesion meets size or morphology thresholds defined by organ-specific guidelines (e.g., ACR TI-RADS category 5 nodules ≥1 cm)
- Staging of a known or suspected malignancy requires histologic confirmation of a distant site

Biopsy may be deferred or contraindicated when:
- Coagulopathy is uncorrected; SIR published consensus guidelines define a platelet threshold of ≥50,000/μL and an INR ≤1.5 for most percutaneous procedures
- Imaging characteristics are sufficiently diagnostic to preclude the need for tissue (e.g., hepatocellular carcinoma meeting LI-RADS LR-5 criteria in a patient with cirrhosis, per ACR LI-RADS v2018)
- No safe percutaneous access route exists and surgical biopsy is preferable
- The patient cannot tolerate the required positioning or cannot cooperate with breath-hold instructions during CT guidance

CNB versus FNA — a direct comparison:

Feature Core Needle Biopsy Fine Needle Aspiration
Needle gauge 14–18 gauge 22–25 gauge
Tissue yield Histologic cores (architecture preserved) Cytologic cells only
Molecular testing suitability High Limited
Bleeding risk Moderate Low
Primary indication Solid masses requiring histology Cysts, thyroid, lymph node triage

Radiologists performing these procedures operate under radiologyauthority.com's broader framework for understanding how imaging intersects with clinical decision-making. Interventional radiology fellowship training, as structured by the Accreditation Council for Graduate Medical Education (ACGME), includes minimum procedural volume requirements for biopsy competency, ensuring that practitioners have logged sufficient supervised cases before independent practice.

Radiation exposure is a relevant consideration for CT-guided procedures; the ACR and the Radiological Society of North America (RSNA) jointly publish dose reference resources, and procedure-specific dose optimization is addressed in institutional protocols aligned with the ALARA (As Low As Reasonably Achievable) principle established under 10 CFR Part 20 (U.S. Nuclear Regulatory Commission).

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)